Spruce Biosciences
SPRB
#9267
Rank
HK$0.78 B
Marketcap
HK$731.38
Share price
15.07%
Change (1 day)
-96.90%
Change (1 year)

Revenue for Spruce Biosciences (SPRB)

Revenue in 2025 (TTM): HK$5.41 Million

According to Spruce Biosciences's latest financial reports the company's current revenue (TTM ) is HK$5.42 Million. In 2024 the company made a revenue of HK$38.12 Million a decrease over the revenue in the year 2023 that were of HK$78.79 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Spruce Biosciences from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$5.41 M-85.81%
2024 HK$38.12 M-51.61%
2023 HK$78.79 M
2022 N/A
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA